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I. EXTENDED ABSTRACT
A. Introduction
The pharmaceutical industry has a clear need for improve-
ment in drug design techniques due to the incremental research
cost for each new drug delivered to the market. To address this
aspect, computer tools play an important role in the reduction
of expenses, specially in early drug discovery (EDD).
EED process can be summarized in three main steps: (1)
target identification and validation, (2) hit finding and (3) hit-
to-lead and lead optimization. In this last step, the main goal
is to refine each hit trying to improve their efficacy, selectiv-
ity, and adequate their ADMET (Administration, Distribution,
Metabolism, Excretion, and Transport) and PK properties[1].
This preclinical research is typically done using reposito-
ries of existent molecules. However, in many cases, there is a
need for completely novel approaches to cure diseases where
current chemical compounds have repeatedly failed. Here is
when computational methods come into play.
There are several strategies to construct new molecules.
One of those is the growing method, which can be split in two
different approaches depending on the size of our ”bricks”:
Atom-based and fragment-based.
Fragment-based have become more popular than the atom
based counterpart, as indicated by the recently developed
programs[2][3]. In fact, the current state of the art for this kind
of software focuses on the growing part, while the evaluation
of the resultant molecules is lagging behind. This is obviously
due to the associated difficulties of computationally predicting
accurate protein-ligand binding free energies. For this reason,
an improvement of the scoring functions would be highly
beneficial for the drug design community.
B. Our approach
In our lab, the Electronic and Atomic Protein Model-
ing lab at Barcelona Supercomputing Center, a state of the
art technique for molecular simulations had been developed.
The method, called Protein Energy Landscape Exploration
(PELE)[4], combines a perturbation step, trough a random
translation and rotation of the ligand, with a relaxation step,
via protein structure prediction techniques and energy min-
imization. The final result of these steps is accepted or re-
jected according to the Metropolis algorithm. The combination
Fig. 1. A simple representation of the slow-growing schema. From a phenyl
molecule, we are building a methyl-phenyl after the addition of a methyl in
four steps (1-4).
of Monte Carlo sampling with protein structure prediction
techniques represents a breakthrough in modeling (sampling)
protein-ligand interactions, in fact, it was recently highlighted
in the latest CSAR challenge (a blind benchmark for docking
and scoring methods) [5] as a remarkable achievement in drug
design.
In relation with the growing part, given an initial protein-
ligand structure, a fragment in PDB format and the linking site,
FrAG (Fragment-based Automatic Growing) is able to set up
all necessary files to run PELE and use it to grow.
The whole process follows a slow-growing scheme as
shown in the Figure 1. Our strategy is based on running
successive PELE simulations at the same time that the growth
is taking place. Before each simulation, FrAG computes a
linear increase of Van Der Waals radius, bond length and
charges modification for all atoms of the fragment to avoid
major alterations in free energy. Then, once PELE has finished,
FrAG analyses the results and choose the best structure that
will be used as input for the next simulation.
Through this method, thanks to PELE’s protein structure
prediction, it is expected to find new spaces to place the
molecule which would be difficult to obtain running ordinary
simulations.
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Fig. 2. Graphical representation of the scoring method. The energy profile has
been generated from the data obtained during PELE simulation. The first point
is identified using the minimum energy value that is considered as the binding
position. The second point is obtained after defining a threshold (treated as
early dissociation state) of SASA and interpolate the value of BE from the
energy profile. Then, the slope between this two points is computed in order
to get the score.
When the growing part has finished it is required to score
the results. In accordance, it is being developed an unbinding
scoring protocol with PELE based on recent work called DUck
by Barril’s lab[6]. In this method, we will use PELE to lead
the ligand outside the binding pocket. During the unbinding,
different measurements of Binding Energy (BE) and Solvent
Accessible Surface Area (SASA) will be computed, and then,
after analyzing the collected data a profile of SASA vs BE can
be done. You can see an example in the Figure 2. Afterward,
our score is the slope computed by the following way:
BEBindingPosition−BEEarlyDissociation
SASABindingPosition− SASAEarlyDissociation (1)
C. Preliminary results
FrAG-PELE has been tested in a simple case of a T4
lysozyme with a benzene bonded (PDB ID: 181L), where we
performed the growing until reaching a phenylethane. This
result was compared with the crystallized structure (PDB ID:
1NHB) and we obtained an RMSD between ligands of 0’956.
The scoring method has been proved in a target where
high-quality binding data for a series of fragment-sized
ligands and the high-quality crystal structure was available[7].
Eleven simulations were performed in DNA Ligase (PDB ID:
4CC5), one for each fragment-sized ligand that we wanted
to score. Finally, we set the threshold in a SASA value of
0’4 and we computed the score for the eleven ligands. A
regression analysis was performed to compare experimental
data (Gibbs free energy calculated) with the score obtained
and we got an R-squared of 0’875.
D. Conclusions
Although that the first results are satisfactory, it is needed
to perform more tests in order to further evaluate our soft-
ware. In future updates, we would like to implement a pre
or post-filtering method in order to take into account the
synthesizability and the ADMET properties of the resultant
molecules. Furthermore, we would like to automatize growing
process, finding automatically which is the best position to
grow the new fragment without user’s intervention. When all
these would be implemented, we think that FrAG-PELE could
be a useful tool for hit-to-lead in EDD.
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